Your session is about to expire
← Back to Search
Interruptive Best Practice Advisory - CDS Intervention for Suicidal Thoughts (CDS_PS Trial)
N/A
Waitlist Available
Led By Colin G Walsh, MD, MA
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up sixty days after study encounter
Awards & highlights
CDS_PS Trial Summary
This trial will test if using a machine learning model to predict suicide risk, and then prompting face-to-face screening with a validated suicide screening tool, can help reduce the number of suicide attempts.
Eligible Conditions
- Suicidal Thoughts
- Suicide Attempt
CDS_PS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ sixty days after study encounter
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~sixty days after study encounter
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Face-to-face screening by clinician
Secondary outcome measures
Emergency Department Utilization
Feeling suicidal (finding)
Subsequent encounter for suicide attempt within sixty days
CDS_PS Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Interruptive Best Practice Advisory - CDS InterventionExperimental Treatment1 Intervention
Adults at Elevated Predicted Risk (>=2% predicted risk, based on our study, DOI: 10.1001/jamanetworkopen.2021.1428) at visit registration (aka "check-in") will be randomized to either Interruptive Alert or Passive Prompt CDS interventions.
In the Interruptive Alert, the physician who next opens that patient's chart will be prompted to review a BPA describing the patient's risk and asking the physician to choose from the BPA options (see Interventions).
The BPA will need to be dismissed to the Epic Storyboard or completed as above to continue clinical workflow.
Group II: Passive Storyboard Prompt - CDS InterventionActive Control1 Intervention
Adult patients in the highest predicted risk tier (>=2% predicted risk, based on our research study, DOI: 10.1001/jamanetworkopen.2021.1428) at the time of visit registration (aka "check-in") will be randomized to either the Interruptive Alert or Passive Prompt CDS intervention arms.
In the Passive Prompt arm, the physician who next opens the patients' charts after check-in (e.g., "Chart Review") will see a Storyboard icon for Elevated Suicide Risk on the left side of the screen. Hovering over this icon will bring up a window with the BPA information in a view identical to the Interruptive Alert arm. Clicking on the window will bring up the BPA with full functionality as in the Interruptive Alert arm.
Find a Location
Who is running the clinical trial?
Vanderbilt University Medical CenterLead Sponsor
858 Previous Clinical Trials
671,697 Total Patients Enrolled
Colin G Walsh, MD, MAPrincipal InvestigatorVanderbilt University Medical Center
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are participants being recruited for this investigation currently?
"Affirmative. The data registered on clinicaltrials.gov implies that this experiment is accepting participants, which was initially posted August 17th of 2022 and recently modified on the 23rd of the same month. 200 volunteers are needed from a single medical centre for enrolment in this trial."
Answered by AI
What is the total sample size of this research endeavor?
"Affirmative, the records on clinicaltrials.gov state that this research trial is currently recruiting individuals for participation. First posted in August 17th 2022 and recently edited on August 23rd 2022, 200 participants are needed from a single site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger